
Mirati Therapeutics (MRTX)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Mirati Therapeutics (MRTX) Stock
Start investing in Mirati Therapeutics (MRTX)
About Mirati Therapeutics (MRTX)
Market cap | $4.12B |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 1.6M |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -4.80x |
Today's range | — |
Debt / equity | — |
52 week range | $27.3 - $64.41 |
5 year debt / equity | 2.69x |
Beta (LTM) | 0.48x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Nov 6, 2023 |
Dividend payable date | — |
Mirati Therapeutics Stock Rating
Mirati Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy MRTX stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in MRTX stock
Navigate to the Explore page. Then, type MRTX into the search bar. When you see MRTX stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased MRTX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Mirati Therapeutics Stock Earnings
The value each MRTX share was expected to gain vs. the value that each MRTX share actually gained.
Mirati Therapeutics (MRTX) reported Q3 2023 earnings per share (EPS) of -$2.49, beating estimates of -$2.83 by 12.01%. In the same quarter last year, Mirati Therapeutics's earnings per share (EPS) was -$3.09. Mirati Therapeutics is expected to release next earnings on 11/06/2023, with an earnings per share (EPS) estimate of $0.